MedTrace Logo

18F-FSPG PET/CT Imaging in Patients With Cancers

NCT03144622 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2019-10-30

No results posted yet for this study

Summary

This study aims to compare the diagnostic performance of 18F-FDG and 18F-FSPG PET/CT in lung, breast, and abdominal cancers before undergoing therapy. In addition, the role of 18F-FSPG PET/CT in evaluating therapy response and prognosis will also be evaluated.

Conditions

  • Pulmonary Cancer
  • Breast Neoplasms
  • Abdominal Cancer

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Mei-Fang Cheng, MD · National Taiwan University Hospital Department of Nuclear Medicine

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-06
Primary Completion
2019-12-31
Completion
2022-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03144622 on ClinicalTrials.gov